Abstract
Background
Gestational diabetes mellitus (GDM) is associated with increased proinflammatory cytokines and is also associated with adverse cardiovascular disease (CVD) outcomes later in life. We aim to evaluate the relationships between uterine arteries vascularization and endothelial dysfunction markers, proinflammatory cytokines, and glycemic and lipid profile in women with GDM.
Methods
Fifty pregnant women were recruited at the third trimester of pregnancy for a prospective cohort study. They were classified into 2 groups: control and GDM. Comparisons of maternal plasma concentrations of endothelial dysfunction markers (vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and plasminogen activator inhibitor 1), proinflammatory cytokines and mediators (interleukin 6 [IL-6], tumor necrosis factor α, vascular endothelial growth factor, placental growth factor, leptin, leukocyte count, and C-reactive protein), lipid profile, glucose, and glycosylated hemoglobin levels were performed. Mean uterine arteries Doppler pulsatility index (PI) was calculated and the relationships between the variables and PI were also analyzed.
Results
Women with GDM showed higher proinflammatory cytokines, however, endothelial dysfunction markers were similar in both groups. In the diabetic group, significant correlations were found between the mean uterine arteries PI and maternal IL-6 (r =.56, P =.01), triglycerides (r =.49; P =.03), total cholesterol/high-density lipoprotein cholesterol (HDLc) ratio (r =.61; P=.006), glucose (r =.62, P=.005), and glycosylated hemoglobin (r =.48; P=.03). A negative significant correlation between mean uterine arteries PI and HDLc (r =−.58; P=.02) was also found.
Conclusion
The proinflammatory status, hyperlipidemia, and metabolic control correlate with uterine blood flow velocity waveforms in women with gestational diabetes.
Similar content being viewed by others
References
Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 2007;30(suppl 2): S141–S146.
Yogev Y, Xenakis EM, Langer O. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol. 2004;191(5):1655–1660.
Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and metaanalysis. Lancet. 2009;373(9677):1773–1779.
Wenger NK. Recognizing pregnancy-associated cardiovascular risk factors. Am J Cardiol. 2014;113(2):406–409.
Mehta PK, Minissian M, Bairey Merz CN. Adverse pregnancy outcomes and cardiovascular risk factor management. Semin Perinatol. 2015;39(4):268–275.
Ghio A, Bertolotto A, Resi V, Volpe L, Di Cianni G. Triglyceride metabolism in pregnancy. Adv Clin Chem. 2011;55:133–153.
Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG. 2015;122(5): 643–651.
López-Tinoco C, Roca M, Fernández-Deudero A, et al. Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine. 2012;58(1):14–19.
Fasshauer M, Blu¨her M, Stumvoll M. Adipokines in gestational diabetes. Lancet Diabetes Endocrinol. 2014;2(6):488–499.
Bartha JL, González-Bugatto F, Fernández-Macías R, et al. Metabolic syndrome in normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol. 2008;137(2):178–184.
Xu Y, Shen S, Sun L, Yang H, Jin B, Cao X. Metabolic syndrome risk after gestational diabetes: a systematic review and meta-analysis. PLoS One. 2014;9(1):e87863.
Heitritter SM, Solomon CG, Mitchell GF, Skali-Ounis N, Seely EW. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab. 2005;90(7):3983–3988.
Roca-Rodríguez MM, López-Tinoco C, Murri M, et al. Postpartum development of endothelial dysfunction and oxidative stress markers in women with previous gestational diabetes mellitus. J Endocrinol Invest. 2014;37(6):503–509.
Metzger BE. The Organizing Committee. Summary and recommendations of the Third International Workshop-Conference on gestational diabetes mellitus. Diabetes Care. 1991;40(suppl 2): 197–201.
Corcoy R, Lumbreras B, Bartha JL, Ricart W; Grupo Español de Diabetes y Embarazo. New diagnostic criteria for gestational diabetes mellitus after the HAPO study. Are they valid in our environment? [in Spanish]. Endocrinol Nutr. 2010;57(6):277–280.
Figueras F, Meler E, Iraola A, et al. Customized birthweight standards for a Spanish population. Eur J Obstet Gynecol Reprod Biol. 2008;136(1):20–24.
Rizvi AA. Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts. Am J Med Sci. 2009;338(4):310–318.
Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ. 2002;325(7356):157–160.
Pietryga M, Brazert J, Wender-Ozegowska E, Biczysko R, Dubiel M, Gudmundsson S. Abnormal uterine Doppler is related to vasculopathy in pregestational diabetes mellitus. Circulation. 2005; 112(16):2496–2500.
Dubiel M, Seremak-Mrozikiewicz A, Breborowicz GH, Drews K, Pietryga M, Gudmundsson S. Fetal and maternal Doppler velocimetry and cytokines in high-risk pregnancy. J Perinat Med. 2005; 33(1):17–21.
Flo K, Blix ES, Husebekk A, et al. A longitudinal study of maternal endothelial function, inflammatory response and uterine artery blood flow during the second half of pregnancy. Acta Obstet Gynecol Scand. 2016;95(2):225–232.
Sokup A, Góralczyk B, Gó ralczyk K, Rość D. Triglycerides as an early pathophysiological marker of endothelial dysfunction in nondiabetic women with a previous history of gestational diabetes. Acta Obstet Gynecol Scand. 2012; 91(2):182–188.
Rye KA, Barter PJ. Cardioprotective functions of HDLs. J Lipid Res. 2014;55(2):168–179.
Stanley JL, Cheung CC, Rueda-Clausen CF, Sankaralingam S, Baker PN, Davidge ST. Effect of gestational diabetes on maternal artery function. Reprod Sci. 2011;18(4):342–352.
López-Tinoco C, Roca M, García-Valero A, et al. Oxidative stress and antioxidant status in patients with late-onset gestational diabetes mellitus. Acta Diabetol. 2013;50(2):201–208.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bugatto, F., Quintero-Prado, R., Visiedo, F.M. et al. The Influence of Lipid and Proinflammatory Status on Maternal Uterine Blood Flow in Women With Late Onset Gestational Diabetes. Reprod. Sci. 25, 837–843 (2018). https://doi.org/10.1177/1933719117698576
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719117698576